HemoCath - Crunchbase Company Profile & Funding

Q: Where is HemoCath's headquarters?

HemoCath is located in Galway, Galway, Ireland.

Q: When was the last funding round for HemoCath?

HemoCath closed its last funding round on obfuscated from a Pre-Seed round.

Overview

HemoCath

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About HemoCath

CB Rank

682688

HemoCath Engineering better solutions for people with heart failure

Founded

obfuscation

Private

Pre-Seed

Galway, Galway, Ireland

1-10

www.hemocath.com/

Health Diagnostics

Medical Device

Funding Rounds

Pre-Seed

OBF

obfuscation

Key People

Des Regan: Co-Founder and Chief Technology Officer
Eric Caron: Co-Founder and CEO

Details

Legal Name

HemoCath Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Christopher Glover, Des Regan, Eric Caron, Michael Nagy

About the Company

HemoCath is a US/Irish pre-revenue startup that has developed and is now commercializing the HemoCath™ PA catheter and the Luc™ HFM platform — offering the potential to improve clinical outcomes and reduce healthcare costs for people with heart failure (HF).

Contact Email

eric@hemocath.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Swan-HemoCath™ Critical Care AI Platform

A platform combining a minimally-invasive pulmonary artery catheter with AI-powered real-time monitoring for managing critically ill and heart failure patients.

HemoCath™ Pulmonary Artery (PA) Catheter

A minimally-invasive catheter inserted via the arm to measure pulmonary artery and central venous pressures for hemodynamic monitoring in critical care.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed
obfuscated obfuscation	Pre Seed Round - HemoCath	—	obfuscated obfuscation	—	Pre-Seed